<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Prescription Not Needed? The Silent Epidemic of Over-The-Counter Medicine Use in India.</title>
    <link>https://www.taxtmi.com/article/detailed?id=15231</link>
    <description>OTC medicine use in India operates within regulatory ambiguity because the Drugs &amp; Cosmetics framework lacks a clear codified OTC category, allowing many medicines to be dispensed without prescription. This gap, coupled with therapeutic-category guidance that omits specific drug names, causes inconsistent enforcement. Recommended reforms include legislating a defined OTC list with dosage, label, and packaging controls; prescribing prescription-only status for high-risk drugs; strengthening pharmacist responsibilities through training and enforceable duties; tightening online pharmacy verification; and enhancing market surveillance and batch testing with swift recall procedures.</description>
    <language>en-us</language>
    <pubDate>Tue, 14 Oct 2025 09:39:53 +0530</pubDate>
    <lastBuildDate>Tue, 14 Oct 2025 09:39:53 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=858287" rel="self" type="application/rss+xml"/>
    <item>
      <title>Prescription Not Needed? The Silent Epidemic of Over-The-Counter Medicine Use in India.</title>
      <link>https://www.taxtmi.com/article/detailed?id=15231</link>
      <description>OTC medicine use in India operates within regulatory ambiguity because the Drugs &amp; Cosmetics framework lacks a clear codified OTC category, allowing many medicines to be dispensed without prescription. This gap, coupled with therapeutic-category guidance that omits specific drug names, causes inconsistent enforcement. Recommended reforms include legislating a defined OTC list with dosage, label, and packaging controls; prescribing prescription-only status for high-risk drugs; strengthening pharmacist responsibilities through training and enforceable duties; tightening online pharmacy verification; and enhancing market surveillance and batch testing with swift recall procedures.</description>
      <category>Articles</category>
      <law>Other Topics</law>
      <pubDate>Tue, 14 Oct 2025 09:39:53 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/article/detailed?id=15231</guid>
    </item>
  </channel>
</rss>